INS and metabolic dysfunction-associated steatotic liver disease: In NAFLD, increased adipogenesis and mitochondrial dysfunction lead to oxidative stress, which can inhibit insulin signaling by activating IKK-β and Jun N-terminal kinase (JNK) [11,12].